P196 Epstein-Barr virus and transforming growth Factor Beta1 in head and neck cancer during concurrent chemo-radiotherapy

2007 ◽  
Vol 2 (1) ◽  
pp. 190
Author(s):  
H.W. Chen ◽  
S.F. Yang ◽  
Y.C. Chang ◽  
J.J. Hwang
2004 ◽  
Vol 118 (3) ◽  
pp. 207-212 ◽  
Author(s):  
T. Powles ◽  
J. Powles ◽  
M. Nelson ◽  
A. Sandison ◽  
D. Peston ◽  
...  

Head and neck cancers have been described in patients with human immunodeficiency virus-1 (HIV-1) infection. However the incidence, aetiology and clinical features of the disease remain unclear.Patients with head and neck cancer and HIV were identified from a large HIV centre. The incidence and clinical features were recorded, and the tumours were stained for Epstein-Barr virus (EBV).Head and neckcancer occurred more frequently than in an age-matched control group (1.66 vs 0.55/10,000 patient years respectively p < 0.05). Highly active anti-retroviral therapy has not significantly altered the incidence of the disease. All of the tumours tested were positive for EBV. Patients were moderately immunosuppressed at diagnosis and had aggressive tumours. All but one of the patients died of cancer with a median survival of 28 months.Head and neck cancer occurs more frequently in HIV. It is an aggressive disease and EBV may play a role in its pathogenesis.


1978 ◽  
Vol 10 (5) ◽  
pp. 457-463 ◽  
Author(s):  
Marlene R. Halili ◽  
Ilya Spigland ◽  
Nan Foster ◽  
Nemetallah A. Ghossein

2008 ◽  
Vol 128 (10) ◽  
pp. 1145-1151 ◽  
Author(s):  
Hong-Wen Chen ◽  
Sheau-Fang Yang ◽  
Yue-Cune Chang ◽  
Tao-Yeung Wang ◽  
Yu-Jen Chen ◽  
...  

2004 ◽  
Vol 114 (6) ◽  
pp. 1027-1031 ◽  
Author(s):  
David Goldenberg ◽  
Nicole E. Benoit ◽  
Shahnaz Begum ◽  
William H. Westra ◽  
Yoram Cohen ◽  
...  

2000 ◽  
Vol 74 (5) ◽  
pp. 2443-2446 ◽  
Author(s):  
Jingwu Xu ◽  
Ali Ahmad ◽  
James F. Jones ◽  
Riccardo Dolcetti ◽  
Emanuela Vaccher ◽  
...  

ABSTRACT Transforming growth factor β (TGF-β) is an immunosuppressive cytokine which can induce immunoglobulin A (IgA) switch and Epstein-Barr virus (EBV) replication in latently infected cells. Here we report elevated serum levels of TGF-β in various EBV-associated diseases correlating positively with EBV-specific IgA titers and negatively with IgM titers, suggesting a role for this cytokine in the pathogenesis of these diseases.


Sign in / Sign up

Export Citation Format

Share Document